Showing results (311-320 of 367) with videos related to
Sort By:
Pageof 37
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2020
Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapyAbhishek S Kashyap, Martina Schmittnaegel, Nicolò Rigamonti, et al.Leukemia|January 8, 2021
A modular and controllable T cell therapy platform for acute myeloid leukemiaMohamed-Reda Benmebarek, Bruno L Cadilha, Monika Herrmann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2019
Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor ImmunotherapyClara H Karches, Mohamed-Reda Benmebarek, Moritz L Schmidbauer, et al.The Journal of Clinical Investigation|May 16, 2012
Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signalingMoritz Felcht, Robert Luck, Alexander Schering, et al.Nature Communications|June 26, 2020
Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibodyMartina Geiger, Kay-Gunnar Stubenrauch, Johannes Sam, et al.Journal for Immunotherapy of Cancer|January 8, 2025
Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironmentJacob Gadwa, Justin Yu, Miles Piper, et al.Journal for Immunotherapy of Cancer|February 11, 2025
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor modelsEneko Garate-Soraluze, Irantzu Serrano-Mendioroz, Leticia Fernández-Rubio, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2023
Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific AntibodiesGabrielle Leclercq-Cohen, Nathalie Steinhoff, Llucia Albertí Servera, et al.Science Translational Medicine|March 13, 2020
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapyMaud Mayoux, Andreas Roller, Vesna Pulko, et al.Archives of Biochemistry and Biophysics|April 3, 2012
Development of tetravalent IgG1 dual targeting IGF-1R-EGFR antibodies with potent tumor inhibitionRebecca Croasdale, Katharina Wartha, Juergen M Schanzer, et al.Pageof 37